NEW YORK (GenomeWeb) – The US Food and Drug Administration's device division has put out a list of guidance documents it intends to publish in 2017, among which include guidelines that would clarify regulations for garnering premarket approval or clearance of devices and diagnostics, particularly next-generation sequencing tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.